Stock Updates

A look at a High Market Cap Stock: Gilead Sciences Inc., GILD

Gilead Sciences Inc., GILD is in the exchange NASDAQ and its industry is Biotechnology in the sector of Healthcare. Based in USA, Gilead Sciences Inc., GILD  has a market cap of 119698.65. Since its IPO date on the 1/22/1992, Gilead Sciences Inc., GILD performance year to date is -13.57%. Today Gilead Sciences Inc., GILD has gained 0.64%, with a current price of 87.1.

Ownership of the company is 0.50% for insider ownership while institutional ownership is 82.00%. The management of the company have seen the company have a payout ratio of 14.30%. Return of assets are at 36.60%, with return on investment at 45.90%.

In terms of debt levels and profit levels, Gilead Sciences Inc., GILD is seeing a long-term debt/equity of 1.57. While Total debt/equity is 1.7. With a profit margin of 52.80%, this is combined with a gross margin of 86.90%, and operating margin of 65.40%. Gilead Sciences Inc. ability to meet debt levels, with a current ratio of 1.8, while the quick ratio is 1.6.

For the last year Gilead Sciences Inc., GILD has seen a EPS growth of 62.00%. A performance for the year of -22.21%. The 52-week high is -26.28%, and the 52-week low is 11.78%. The average volume for Gilead Sciences Inc., GILD is 5877.

With a target price of 110.58, can Gilead Sciences Inc., GILD reach this target? Looking at the value indicators of Gilead Sciences Inc., GILD. Gilead Sciences Inc. has a P/E of 7.4 and a forward P/E of 7.02. Perhaps the more useful indicator than P/E, is PEG which has a value of 11.48. Gilead Sciences Inc. also has a P/S and a P/B of 3.65 and 8.93 respectively. For P/cash, Gilead Sciences Inc. has a value of 14.39, while it is 7.52 for P/free cash flow.

At the current price of 87.1, Gilead Sciences Inc. has a dividend yield of 2.17%. We see a return on equity of 105.70%.

Looking more long-term Gilead Sciences Inc., is projected to get an EPS growth for the next five years of 0.65%. In the short-term an EPS growth of 2.06% in the next year is forecasted. This is after a EPS growth of 62.00% for this year and for the last five years a 48.30% growth has been seen.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Mark Hines

Leave a Comment